ANGO vs NTAP · rev $292.5M vs P/E 28, rev $6.57B
AngioDynamics Inc (ANGO) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
ANGO currently screens at market cap $378.5M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the ANGO and NTAP stock pages for the full models.
Not investment advice.